Raja Mudad, MD, FACP, discusses the RELAY trial and using doublet therapy to treat EGFR-mutant non–small cell lung cancer.
Raja Mudad, MD, FACP
Advertisement
Articles by Raja Mudad, MD, FACP
Advertisement
Latest Updated Articles
Dr. Mudad on RELAY Trial for EGFR-Mutant NSCLCPublished: October 3rd 2019 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
PreBLA Meeting With FDA Sinks uniQure’s Hopes for Approval of Huntington Disease Gene Therapy AMT-130 Based Primarily on Phase 1/2 Data
2
FDA Activity Recap: October 2025 Features New Platform Technology Designation, RDEA Pilot Program Selection, and More
3
